MedPath

Red De Terapia Celular

Red De Terapia Celular logo
🇪🇸Spain
Ownership
Private
Established
2006-01-01
Employees
251
Market Cap
-
Website
https://www.red-tercel.com

Use of the Amniotic Membrane in Large Wound Epithelialization

Phase 1
Completed
Conditions
Wounds
Interventions
Procedure: Place amniotic membrane in large wounds
Procedure: Obtaining and Cryopreservation of amniotic membrane
Drug: amniotic membrane
First Posted Date
2013-04-04
Last Posted Date
2017-03-30
Lead Sponsor
Red de Terapia Celular
Target Recruit Count
6
Registration Number
NCT01824381
Locations
🇪🇸

Clinical Universitary Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain

Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.

Phase 1
Completed
Conditions
Liver Transplantation
Immunosuppression
Interventions
Procedure: Extracorporeal Photopheresis Procedure (FEC)
First Posted Date
2013-04-04
Last Posted Date
2017-03-30
Lead Sponsor
Red de Terapia Celular
Target Recruit Count
10
Registration Number
NCT01824368
Locations
🇪🇸

University Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain

PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells

Phase 2
Completed
Conditions
Osteonecrosis of the Femoral Head
Interventions
Procedure: bone marrow aspirate
First Posted Date
2012-10-04
Last Posted Date
2017-03-30
Lead Sponsor
Red de Terapia Celular
Target Recruit Count
3
Registration Number
NCT01700920
Locations
🇪🇸

University Hospital of Salamanca, Salamanca, Castilla y León, Spain

Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells

Phase 1
Completed
Conditions
Osteoarthritis, Knee
Arthritis of Knee
Knee Osteoarthritis
Interventions
Other: Allogenic mesenchymal stromal cells injection
First Posted Date
2012-04-26
Last Posted Date
2015-10-16
Lead Sponsor
Red de Terapia Celular
Target Recruit Count
30
Registration Number
NCT01586312
Locations
🇪🇸

Centro Medico Teknon, Barcelona, Spain

🇪🇸

Hospital Clinico Universitario, Valladolid, Spain

Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease

Phase 1
Completed
Conditions
Intervertebral Disc Disease
Interventions
Procedure: Instrumented posterolateral arthrodesis
First Posted Date
2012-01-20
Last Posted Date
2017-06-02
Lead Sponsor
Red de Terapia Celular
Target Recruit Count
15
Registration Number
NCT01513694
Locations
🇪🇸

Trauma Service. Hospital Universitario de Salamanca, Salamanca, Castilla-León, Spain

Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)

Phase 1
Completed
Conditions
Maxillary Cyst
Bone Loss of Substance
Interventions
Biological: MSV treatment
First Posted Date
2011-07-08
Last Posted Date
2017-04-27
Lead Sponsor
Red de Terapia Celular
Target Recruit Count
11
Registration Number
NCT01389661
Locations
🇪🇸

Río Hortega University Hospital, Valladolid, Valladid, Spain

🇪🇸

Instituto de Biologia y Genetica Molecular, Valladolid, Spain

🇪🇸

Bionand, Parque Tecnológico de Andalucía, Universidad de Málaga, Malaga, Spain

Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells

Phase 1
Completed
Conditions
Osteoarthritis, Knee
Knee Osteoarthritis
Knee Degenerative Disease
Interventions
Other: Autologous bone marrow mesenchymal stem cells (MSV)
First Posted Date
2010-08-18
Last Posted Date
2015-01-15
Lead Sponsor
Red de Terapia Celular
Target Recruit Count
12
Registration Number
NCT01183728
Locations
🇪🇸

Instituto de Biologia y Genetica Molecular (IBGM), University of Valladolid, Valladolid, Spain

🇪🇸

Teknon Medical Center, ITRT, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath